Personalized prediction of anticancer potential of non-oncology drugs through learning from genome derived molecular pathways
Abstract Advances in cancer genomics have significantly expanded our understanding of cancer biology. However, the high cost of drug development limits our ability to translate this knowledge into precise treatments. Approved non-oncology drugs, comprising a large repository of chemical entities, of...
Saved in:
Main Authors: | Xiaobao Dong, Huanhuan Liu, Ting Tong, Liuxing Wu, Jianhua Wang, Tianyi You, Yongjian Wei, Xianfu Yi, Hongxi Yang, Jie Hu, Haitao Wang, Xiaoyan Wang, Mulin Jun Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2025-02-01
|
Series: | npj Precision Oncology |
Online Access: | https://doi.org/10.1038/s41698-025-00813-z |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phytomedicinal armamentarium: A review of inula racemosa-derived alantolactones and isoalantolactones in anticancer therapy
by: Joshi Gaurav Santoshrao, et al.
Published: (2025-02-01) -
5-Fluorouracil-β-Cyclodextrin conjugates:Linker strategies to enhance the anticancer efficacy and reduce the side effects
by: Liangliang Hu, et al.
Published: (2025-03-01) -
Abeloff's Clinical Oncology /
by: Niederhuber, John E.
Published: (2014) -
Exploring the anticancer potential of Hewittia malabarica through phytochemical analysis and molecular docking study
by: Shiji Thozhukkad Moosaripparambil, et al.
Published: (2025-02-01) -
A minimalist cardio-oncology service: A personal experience from Wales
by: Riaz Muhammad Hamza, et al.
Published: (2024-11-01)